At 26 weeks , the adjusted mean change in HbA1c was greater in patients receiving dulaglutide 15 mg ( -164 % [ 95 % CI -178 to -150 ] , -1793 mmol/mol [ -1944 to -1642 ] ) and dulaglutide 075 mg ( -159 % [ -173 to -145 ] , -1738 mmol/mol [ -1889 to -1587 ] ) than in those receiving glargine ( -141 % [ -155 to -127 ] , -1541 mmol/mol [ -1692 to -1390 ] ) .